JPH0314020B2 - - Google Patents
Info
- Publication number
- JPH0314020B2 JPH0314020B2 JP57071425A JP7142582A JPH0314020B2 JP H0314020 B2 JPH0314020 B2 JP H0314020B2 JP 57071425 A JP57071425 A JP 57071425A JP 7142582 A JP7142582 A JP 7142582A JP H0314020 B2 JPH0314020 B2 JP H0314020B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- dimethyl
- dihydropyridine
- compound
- nitrophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57071425A JPS58208271A (ja) | 1982-04-30 | 1982-04-30 | 1,4−ジヒドロピリジン誘導体 |
EP83104076A EP0093945B1 (en) | 1982-04-30 | 1983-04-26 | 1,4-dihydropyridine derivatives |
DE8383104076T DE3378533D1 (en) | 1982-04-30 | 1983-04-26 | 1,4-dihydropyridine derivatives |
US06/490,167 US4495192A (en) | 1982-04-30 | 1983-04-29 | 1-Substituted 1,4-dihydropyridines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57071425A JPS58208271A (ja) | 1982-04-30 | 1982-04-30 | 1,4−ジヒドロピリジン誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58208271A JPS58208271A (ja) | 1983-12-03 |
JPH0314020B2 true JPH0314020B2 (en, 2012) | 1991-02-25 |
Family
ID=13460138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57071425A Granted JPS58208271A (ja) | 1982-04-30 | 1982-04-30 | 1,4−ジヒドロピリジン誘導体 |
Country Status (4)
Country | Link |
---|---|
US (1) | US4495192A (en, 2012) |
EP (1) | EP0093945B1 (en, 2012) |
JP (1) | JPS58208271A (en, 2012) |
DE (1) | DE3378533D1 (en, 2012) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4833150A (en) * | 1985-03-14 | 1989-05-23 | Nelson Research & Development Co. | 1,4-dihydropyridines |
US4849436A (en) * | 1986-03-11 | 1989-07-18 | Nelson Research & Development Co. | 1,4-dihydropyridines |
US4920225A (en) * | 1986-12-22 | 1990-04-24 | Laboratoires Syntex S.A. | Resolution of 1,4-dihydropyridine derivatives |
AU1107888A (en) * | 1986-12-29 | 1988-07-27 | Pharmacia Ab | Nitroxide compounds for the preparation of a pharmaceutical composition intended for the prophylaxis and treatment of ischemic cell damage |
GB8721986D0 (en) * | 1987-09-18 | 1987-10-28 | Ici Plc | Pyridine derivative |
US5254637A (en) * | 1991-06-03 | 1993-10-19 | Eastman Kodak Company | Thermosetting coating compositions |
US5247122A (en) * | 1991-06-03 | 1993-09-21 | Eastman Kodak Company | Thermosetting coating compositions |
PE20071079A1 (es) * | 2005-11-15 | 2007-12-16 | Cytokinetics Inc | Compuestos de piperidina como inhibidores de la proliferacion celular |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3966948A (en) * | 1970-01-24 | 1976-06-29 | Bayer Aktiengesellschaft | Spasmolytic, vaso-dilating and anti-hypertensive compositions and methods |
US4021434A (en) * | 1972-01-22 | 1977-05-03 | Yamanouchi Pharmaceutical Co., Ltd. | Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate |
GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
US4307103A (en) * | 1978-09-08 | 1981-12-22 | Fujisawa Pharmaceutical Co., Ltd. | Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same |
DE3018259A1 (de) * | 1980-05-13 | 1981-11-19 | Bayer Ag, 5090 Leverkusen | 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
-
1982
- 1982-04-30 JP JP57071425A patent/JPS58208271A/ja active Granted
-
1983
- 1983-04-26 DE DE8383104076T patent/DE3378533D1/de not_active Expired
- 1983-04-26 EP EP83104076A patent/EP0093945B1/en not_active Expired
- 1983-04-29 US US06/490,167 patent/US4495192A/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
CHEMICAL ABSTRACT * |
Also Published As
Publication number | Publication date |
---|---|
EP0093945B1 (en) | 1988-11-23 |
EP0093945A2 (en) | 1983-11-16 |
JPS58208271A (ja) | 1983-12-03 |
EP0093945A3 (en) | 1984-09-12 |
DE3378533D1 (en) | 1988-12-29 |
US4495192A (en) | 1985-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU187868B (en) | Process for producing dihydropyridine derivatives | |
EP0094159A1 (en) | Dihydropyridine derivatives, their production and use | |
CA2046495A1 (fr) | Derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
CA1246078A (en) | ( )-2,6-dimethyl-4-(3-nitrophenil)-1,4- dihydropyridine-3,5-decarboxylicacid-3-(1-benzyl-3- piperidyl)ester-5-methylester | |
JPS6160657A (ja) | エチレンジアミンモノアミド誘導体 | |
CH633266A5 (en) | Process for preparing 1,4-dihydropyridine compounds | |
JPH0314020B2 (en, 2012) | ||
US4243666A (en) | 4-Amino-2-piperidino-quinazolines | |
US4937242A (en) | 1,4-dihydropyridine derivatives and pharmaceutical composition thereof | |
JPS61257983A (ja) | 1,4−ジヒドロピリジン及びこれを有効成分とする医薬組成物 | |
WO1996004268A1 (fr) | Compose de 1,4-dihydropyridine et composition medicinale contenant ledit compose | |
JP2008501732A (ja) | Ccr5拮抗剤としての化合物 | |
JP3839813B2 (ja) | カンプトテシン誘導体の調製に有用な化合物 | |
EP0126654B1 (en) | Tetrahydroisoxazolo(4,5-c)pyridine derivatives and preparation thereof | |
FR2753970A1 (fr) | Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique | |
EP0106276B1 (en) | 1,4-dihydropyridine derivatives | |
JPS62281860A (ja) | アルキレンアミノアルキレン ヘテロ原子基を有するジヒドロ−3,5−ジカルボキシレ−ト | |
JP2640245B2 (ja) | 1,4−ジヒドロピリジン誘導体 | |
JPS6352031B2 (en, 2012) | ||
JP2664941B2 (ja) | 1,4―ジヒドロピリジン化合物 | |
JPH04234363A (ja) | 新規な置換ピペリジン類及びコレステロ−ル合成の阻害剤としてのそれらの用途 | |
JP4324381B2 (ja) | Tnf活性を有するフェニル−およびピリジル−ピペリジン類 | |
JP2967989B2 (ja) | テトラヒドロピリジン誘導体及びその製法 | |
JP2002511451A (ja) | アザシクロアルカン誘導体、その製造及び治療上の使用 | |
GB2050375A (en) | 4-Cyanophenyl-1,4- dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same |